title: Patient receipt and understanding of written information provided with isotretinoin and estrogen prescriptions.
abstract: BACKGROUND
  Medication guides (MG) and mandatory patient package inserts (MPPI) are required with some prescription medications.
  
  
  OBJECTIVE
  We sought to determine how many patients receive, read, and understand these mandated materials.
  
  
  METHODS
  A total of 3,620 patients were identified as filling prescriptions for isotretinoin or selected estrogen products from February 2004 to January 2005. Patients were surveyed to gauge receipt and understanding of the MG for isotretinoin and the MPPI for estrogen.
  
  
  RESULTS
  A total of 500 patients completed the survey, with 186 (93%) of the 200 isotretinoin patients and 258 (86%) of the 300 estrogen patients reporting receipt of the MG/MPPI with their most recent prescription. The majority of respondents reported confidence in their knowledge of their medication (86% for isotretinoin and 75% for estrogen). However, the mean score on 5 questions assessing recognition of medication risks was only slightly better than the score expected from guessing (3.1 vs 2.5, P < .01 for both isotretinoin and estrogen).
  
  
  CONCLUSIONS
  Despite receiving the information and reporting confidence in medication knowledge, patients' understanding of major risks with these medications was poor. This finding highlights the need to develop better risk communication strategies to improve the safe and effective use of prescription medications.
authors.affiliation: Duke Center for Education and Research on Therapeutics, Duke Clinical Research Institute, Durham, NC 27715, USA. allen003@mc.duke.edu
authors.forename: Nancy M
authors.initials: NM
authors.lastname: Allen LaPointe
authors.forename: Paul
authors.initials: P
authors.lastname: Pappas
authors.forename: Patricia
authors.initials: P
authors.lastname: Deverka
authors.forename: Kevin J
authors.initials: KJ
authors.lastname: Anstrom
mesh_terms: D000328:Adult; D003879:Dermatologic Agents / Q000494:pharmacology*; D004348:Drug Labeling; D011307:Drug Prescriptions; D004967:Estrogens / Q000494:pharmacology*; D004966:Estrogens, Conjugated (USP) / Q000494:pharmacology*; D005260:Female; D006801:Humans; D015474:Isotretinoin / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D010353:Patient Education as Topic; D011795:Surveys and Questionnaires
chemical_list: D003879:Dermatologic Agents; D004967:Estrogens; D004966:Estrogens, Conjugated (USP); D015474:Isotretinoin